CD42c activators, as referred to in this context, are chemicals or biological agents that indirectly influence the activity of CD42c (Glycoprotein IIIa) by affecting platelet activation and aggregation pathways. CD42c is a crucial component of the platelet GPIIb/IIIa complex, which plays a fundamental role in the formation of platelet plugs in blood clotting. Direct activators targeting CD42c are less common, and the focus here is on substances that enhance or influence the aggregation process where CD42c is involved. Substances like ADP, Thrombin, and Collagen are key players in platelet activation. ADP binds to platelet receptors and promotes aggregation, indirectly activating CD42c. Thrombin, a potent coagulation factor, induces conformational changes in GPIIb/IIIa, enhancing CD42c function. Collagen interaction with platelets is part of the natural hemostatic response, indirectly promoting CD42c activation.
Epinephrine and Arachidonic Acid play significant roles in platelet function. Epinephrine enhances platelet aggregation through adrenergic receptors, indirectly affecting CD42c, while Arachidonic Acid is metabolized to thromboxane A2, a promoter of aggregation. Calcium Ionophores, by increasing intracellular calcium, also play a role in activating platelets and indirectly CD42c. Ristocetin is known for its ability to induce platelet agglutination under certain conditions, indirectly influencing CD42c. Serotonin (5-HT) and Platelet Activating Factor (PAF) are other agents enhancing platelet aggregation, thereby affecting CD42c activity. The von Willebrand Factor is crucial for mediating platelet adhesion and aggregation, indirectly influencing CD42c function. U46619, a thromboxane A2 analog, mimics the action of thromboxane A2, promoting aggregation and influencing CD42c. Convulxin, a component of snake venom, also induces platelet aggregation, thereby affecting CD42c activity. Understanding these activators provides insights into the complex mechanisms of platelet aggregation and clot formation, highlighting the essential role of CD42c in hemostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine-5′-Diphosphate, free acid | 58-64-0 | sc-291846 sc-291846A sc-291846B sc-291846C sc-291846D sc-291846E | 100 mg 500 mg 1 g 10 g 100 g 500 g | $77.00 $180.00 $312.00 $924.00 $4596.00 $9186.00 | 1 | |
Indirectly activates CD42c by binding to platelet receptors, promoting platelet aggregation. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $230.00 | ||
Acts on platelets to induce conformational changes in GPIIb/IIIa, enhancing CD42c activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Stimulates platelet aggregation, indirectly enhancing CD42c activity through adrenergic receptors. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
Metabolized to thromboxane A2 in platelets, promoting aggregation and indirectly affecting CD42c. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium in platelets, indirectly promoting CD42c activation. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $520.00 | 3 | |
Can enhance platelet aggregation, indirectly influencing CD42c activity. | ||||||
PAF C-16 | 74389-68-7 | sc-201009 sc-201009A | 5 mg 25 mg | $128.00 $294.00 | 10 | |
Indirectly activates CD42c by inducing platelet aggregation. | ||||||
U-46619 | 56985-40-1 | sc-201242 sc-201242A | 1 mg 10 mg | $240.00 $1275.00 | 40 | |
Mimics the action of thromboxane A2, promoting platelet aggregation and influencing CD42c. | ||||||